Overnutrition clinical trials
The registry lists 42 studies for Overnutrition across more than 10 countries. 7 are recruiting or about to start. 1 of them are mainly about Overnutrition (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 9 narrower conditions too, such as Obesity: 13,895 studies, 2,413 open.
Get an email when these change. Save the Overnutrition studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Eli Lilly and Company (6) · Pfizer (3) · University of Copenhagen (2) · Debre Berhan University (2) · Maimonides Medical Center (1) · University of Texas Southwestern Medical Center (1) · University of Aarhus (1) · Duke University (1)
What is being tested here
Drugs under test in Overnutrition studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Berobenatide | 1 | 2 | 2 |
| Tirzepatide | 1 | 0 | 2 |
| Orforglipron | 0 | 1 | 1 |
| Eloralintide | 0 | 0 | 1 |
| Mazdutide | 0 | 0 | 1 |
| Guanfacine | 0 | 0 | 1 |
| Retatrutide | 0 | 0 | 1 |
| Micafungin | 0 | 0 | 1 |
| Betahistine | 0 | 0 | 1 |
| Naltrexone | 0 | 1 | 1 |
Drug classes tested here GLP-1 receptor agonists 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2, phase 3 first
Who these studies take
Of the 6 Overnutrition studies recruiting now, 3 (50%) set no upper age limit and 3 (50%) stop at 75 or younger. 2 (33%) take children under 18. 1 (17%) are for women only and 0 (0%) for men only; 3 (50%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 6 (100%) | 5 (83%) |
| 30 | 5 (83%) | 5 (83%) |
| 40 | 5 (83%) | 5 (83%) |
| 50 | 5 (83%) | 5 (83%) |
| 65 | 4 (67%) | 4 (67%) |
| 75 | 3 (50%) | 3 (50%) |
| 85 | 3 (50%) | 3 (50%) |
Across all 42 studies, recruiting or not: 69% stop at 75 or younger and 50% at 65; 31% take children; 7% are for women only and 7% for men only; 48% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 13, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 42 of 42. search them.
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruitingNCT07595549Phase 311 countries
- A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 DiabetesNot yet recruitingNCT07890376Phase 22 countries
- Acute Metabolic Effects of Tirzepatide in Type 1 DiabetesRecruitingNCT06820281Phase 21 country
- Inflammation's Impact on Heart Disease and DiabetesRecruitingNCT067520181 country
- Longitudinal Monitoring During Intermittent Fasting Protocols in Obese AdultsRecruitingNCT06323889Not applicable1 country
- In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 DiabetesRecruitingNCT06557317Not applicable1 country
- The Extension of HAPO Follow-up StudyRecruitingNCT054775111 country
- The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for ObesityCompletedNCT003427321 country
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or ObesityActive, not recruitingNCT07575932Phase 22 countries
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Active, not recruitingNCT07400653Phase 311 countries
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneeActive, not recruitingNCT07153471Phase 37 countries
- Double Duty Interventions and Its Impact on Double Burden of Malnutrition in Children Under Five YearsActive, not recruitingNCT05791305Not applicable1 country
- A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or OverweightCompletedNCT06230523Phase 21 country
- A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or OverweightCompletedNCT06124807Phase 21 country
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityActive, not recruitingNCT06037252Phase 24 countries
- Balance: A Pragmatic Trial of a Digital Health Intervention to Prevent Weight Gain in Primary CareCompletedNCT03003403Not applicable1 country
- Nutritional and Physical Activities for Overweight and Obese Older AdultsCompletedNCT05804019Not applicable1 country
- The Impact of School-Based Intervention for 9-13-year-old School Children with Overweight and ObesityCompletedNCT06671964Not applicable1 country
- Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & ProvidersCompletedNCT03843424Not applicable1 country
- Promoting Food Acceptance Through Positive Parenting: the Play and Grow StudyCompletedNCT06074926Not applicable1 country
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi SyndromeCompletedNCT05657860Phase 41 country
- Family-based Lifestyle Intervention Program and Carotenoid Supplementation for Children With ObesityCompletedNCT02060279Not applicable1 country
- Food Intake and Epigenetic Alteration in the Spermatozoa of Singletons and TwinsCompletedNCT05368194Not applicable1 country
- A Study of LY3437943 in Participants Who Have Obesity or Are OverweightCompletedNCT04881760Phase 22 countries
- The Effect of Double Duty Interventions on Double Burden of Malnutrition Among School Adolescents in EthiopiaCompletedNCT05574842Not applicable1 country
- Experimental Overfeeding in HumansCompletedNCT04065243Not applicable1 country
- Early Life Nutritional Exposures and Long-term Health and Cognitive OutcomesCompletedNCT019797701 country
- Safety, Tolerability and Efficacy Study of PP1420 in HVTerminatedNCT02221765Phase 1/21 country
- Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese VolunteersCompletedNCT01090141Phase 41 country
- Comparative Analysis Between Sleeve Gastrectomy and Roux-en Y Gastric Bypass in Bariatric OperationStatus unknownNCT04554758Not applicable1 country
- Effects of Betahistine Hydrochloride in Overweight WomenCompletedNCT00459992Phase 11 country
- Clinical Investigation on the Safety of Avocado Pulp LipidsCompletedNCT03898505Early Phase 11 country
- The Colorado LEAP Study: A Socioecological Approach to Obesity Prevention in Early ChildhoodCompletedNCT01937481Not applicable1 country
- Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH StudyCompletedNCT01435603Not applicable1 country
- The Early Stockholm Obesity Prevention Project in ChinaStatus unknownNCT024098751 country
- Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)TerminatedNCT01601704Phase 31 country
- The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass OperationStatus unknownNCT023725261 country
- Trial of a Sugar-Sweetened Beverage Intervention in Overweight Mothers and Their Children Ages 3-5CompletedNCT02098902Not applicable1 country
- Energy Expenditure, Sleep and MacronutrientsStatus unknownNCT01551238Not applicable1 country
- Craving and Lifestyle Management Through Mindfulness StudyCompletedNCT01250509Phase 21 country
- Balance System Study in Type 2 Diabetic PatientsCompletedNCT00872846Phase 11 country
- Acute Effects of Glucose Dependent Insulinotropic Polypeptide (GIP) on Subcutaneous Adipose TissueCompletedNCT00774488Not applicable